You will receive alerts when there are new announcements on Adaptimmune Therapeutics PLC
Only registered members can use this feature.
or
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.
Copyright © Proactive Investors 2021.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.
